{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:35:13Z","timestamp":1782448513213,"version":"3.54.5"},"reference-count":57,"publisher":"Bentham Science Publishers Ltd.","issue":"10","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDD"],"published-print":{"date-parts":[[2019,12,27]]},"abstract":"<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>Floating drug delivery system (FDDS) is the main approach to prolonging the gastric residence\ntime in the stomach in which the bilayer floating tablet has the main role. It is more suitable for\nthe treatment of local infections such as peptic ulcer, gastritis, Zollinger-Ellision syndrome, indigestion,\nand other local infections related to the gastrointestinal tract and also used for systemic applications.\nFDDS provides protection for those drugs which are acid labile and have a short half-life. It also improves\nbioavailability, reduces drug waste, and enhances the residence time of drugs. Nowadays, various\ntechnologies are being used for the development of FDDS. Novel drug delivery systems incorporation\ninto bilayer floating tablets have also broadened the role of FDDS. Polymers have the main role in\nthe development of FDDS, which serve as carriers for the drug and determine the gastric retention time\nand drug protection. FDDS is also an easy, cheap, and more convenient method for dual drug delivery\nof drugs.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1567201816666191018163519","type":"journal-article","created":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T03:26:21Z","timestamp":1571628381000},"page":"874-886","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Floating Drug Delivery Systems: An Emerging Trend for the Treatment of Peptic Ulcer"],"prefix":"10.2174","volume":"16","author":[{"given":"Ankit","family":"Namdev","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Dr. Hari Singh Gour Central University, Sagar (MP), India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2528-2935","authenticated-orcid":true,"given":"Dharmendra","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Dr. Hari Singh Gour Central University, Sagar (MP), India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/B978-0-12-374934-5.00049-0","author":"Holton J.","year":"2010","unstructured":"Holton J.;  Peptic ulcer disease Essentials of Genomic and Personalized Medicine by Ginsburg GS 2010,627-642","journal-title":"Peptic ulcer disease Essentials of Genomic and Personalized Medicine by Ginsburg GS"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.mpmed.2015.01.008","volume":"43","author":"Oppong P.","year":"2015","unstructured":"Oppong P.; Majumdar D.; Atherton J.; Helicobacter pylori infection and peptic ulcers. Medicine (Baltimore) 2015,43(4),215-222","journal-title":"Medicine (Baltimore)"},{"key":"ref=3","first-page":"1005","volume":"76","author":"Ramakrishnan K.","year":"2007","unstructured":"Ramakrishnan K.; Salinas R.C.; Peptic ulcer disease. Am Fam Physician 2007,76(7),1005-1012","journal-title":"Am Fam Physician"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.paed.2014.06.003","volume":"24","author":"Urs A.N.","year":"2014","unstructured":"Urs A.N.; Narula P.; Thomson M.; Peptic ulcer disease. Paediatr Child Health 2014,24,485-490","journal-title":"Paediatr Child Health"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jpsychores.2005.08.009","volume":"60","author":"Jones M.P.","year":"2006","unstructured":"Jones M.P.; The role of psychosocial factors in peptic ulcer disease: Beyond Helicobacter pylori and NSAIDs. J Psychosom Res 2006,60(4),407-412","journal-title":"J Psychosom Res"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0140-6736(16)32404-7","volume":"390","author":"Lanas A.","year":"2017","unstructured":"Lanas A.; Chan F.K.L.; Peptic ulcer disease. Lancet 2017,390(10094),613-624","journal-title":"Lancet"},{"key":"ref=7","first-page":"26","volume":"14","author":"Rawla P.","year":"2019","unstructured":"Rawla P.; Barsouk A.; Epidemiology of gastric cancer: Global trends, risk factors and prevention. Prz Gastroenterol 2019,14(1),26-38","journal-title":"Prz Gastroenterol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S2222-1808(14)60796-9","volume":"5","author":"Arora N.","year":"2015","unstructured":"Arora N.; Majumder K.; Gupta A.; Gastric cancer and the microbiome. Asian Pac J Trop Dis 2015,5,353-357","journal-title":"Asian Pac J Trop Dis"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.mpsur.2014.09.005","volume":"32","author":"Proctor M.J.","year":"2014","unstructured":"Proctor M.J.; Deans C.; Complications of peptic ulcers. Surgery 2014,32,599-607","journal-title":"Surgery"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.cgh.2005.10.006","volume":"4","author":"Papatheodoridis G.V.","year":"2006","unstructured":"Papatheodoridis G.V.; Sougioultzis S.; Archimandritis A.J.; Effects of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on peptic ulcer disease: A systematic review. Clin Gastroenterol Hepatol 2006,4(2),130-142","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"359","DOI":"10.7326\/0003-4819-109-5-359","volume":"109","author":"Griffin M.R.","year":"1988","unstructured":"Griffin M.R.; Ray W.A.; Schaffner W.; Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. Ann Intern Med 1988,109(5),359-363","journal-title":"Ann Intern Med"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3109\/00365529208999950","volume":"27","author":"Lanas A.","year":"1992","unstructured":"Lanas A.; Hirschowitz B.I.; Influence of smoking on basal and on vagally and maximally stimulated gastric acid and pepsin secretion. Scand J Gastroenterol 1992,27(3),208-212","journal-title":"Scand J Gastroenterol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.bpg.2015.12.003","volume":"30","author":"Boltin D.","year":"2016","unstructured":"Boltin D.; Probiotics in Helicobacter pylori-induced peptic ulcer disease. Best Pract Res Clin Gastroenterol 2016,30(1),99-109","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jab.2017.10.007","volume":"1","author":"Shapla U.M.","year":"2018","unstructured":"Shapla U.M.; Raihan J.; Islam A.; Alam F.; Solayman N.; Gan S.H.; Hossen S.; Khalil I.; Propolis: The future therapy against Helicobacter pylori-mediated gastrointestinal diseases. J Appl Biomed 2018,1,81-99","journal-title":"J Appl Biomed"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.giec.2011.07.011","volume":"21","author":"Wang A.Y.","year":"2011","unstructured":"Wang A.Y.; Peura D.A.; The prevalence and incidence of Helicobacter pylori-associated peptic ulcer disease and upper gastrointestinal bleeding throughout the world. Gastrointest Endosc Clin N Am 2011,21(4),613-635","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S1359-6446(97)01044-1","volume":"2","author":"Makovec F.","year":"1997","unstructured":"Makovec F.; D\u2019Amato M.; CCKB\/gastrin receptor antagonists as potential drugs for peptic ulcer therapy. Drug Discov Today 1997,2,283-293","journal-title":"Drug Discov Today"},{"key":"ref=17","first-page":"136","volume":"3","author":"Kansara S.","year":"2013","unstructured":"Kansara S.; Sakhreliya B.D.; Peptic ulcer - Its Pathogenesis and Recent Approaches for the Treatment. J Pharm Sci Bio Res 2013,3,136-144","journal-title":"J Pharm Sci Bio Res"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jscs.2012.03.002","volume":"17","author":"Awaad A.S.","year":"2012","unstructured":"Awaad A.S.; El-Meligy R.M.; Soliman G.A.; Natural products in treatment of ulcerative colitis and peptic ulcer. J Saudi Chem Soc 2012,17,101-124","journal-title":"J Saudi Chem Soc"},{"key":"ref=19","first-page":"647","author":"Tripathi K.D.","year":"2015","unstructured":"Tripathi K.D.;  Essential of medical Pharmacology 2015,647-656","journal-title":"Essential of medical Pharmacology"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.5056\/jnm.2013.19.1.25","volume":"19","author":"Shin J.M.","year":"2013","unstructured":"Shin J.M.; Kim N.; Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors. J Neurogastroenterol Motil 2013,19(1),25-35","journal-title":"J Neurogastroenterol Motil"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/0016-5085(79)90002-7","volume":"77","author":"Robert A.","year":"1979","unstructured":"Robert A.; Nezamis J.E.; Lancaster C.; Hanchar A.J.; Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology 1979,77(3),433-443","journal-title":"Gastroenterology"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/0883-2897(89)90106-2","volume":"16","author":"Petersen J.M.","year":"1989","unstructured":"Petersen J.M.; Caride V.J.; Prokop E.K.; Troncale F.J.; McCallum R.W.; Sucralfate delays gastric emptying of liquids and solids in duodenal ulcer patients. Int J Rad Appl Instrum B 1989,16(4),389-395","journal-title":"Int J Rad Appl Instrum B"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"102S","DOI":"10.1016\/0002-9343(91)90459-B","volume":"91","author":"Hunt R.H.","year":"1991","unstructured":"Hunt R.H.; Treatment of peptic ulcer disease with sucralfate: A review. Am J Med 1991,91(2A),102S-106S","journal-title":"Am J Med"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1001\/jama.1996.03530320046033","volume":"275","author":"Soll A.H.","year":"1996","unstructured":"Soll A.H.; Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. JAMA 1996,275(8),622-629","journal-title":"JAMA"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vaccine.2018.01.001","volume":"5","author":"Sutton P.","year":"2018","unstructured":"Sutton P.; Boag J.M.; Status of vaccine research and development for Helicobacter pylori. Vaccine 2018,5,1-5","journal-title":"Vaccine"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2165\/00003495-197611040-00002","volume":"11","author":"Pinder R.M.","year":"1976","unstructured":"Pinder R.M.; Brogden R.N.; Sawyer P.R.; Speight T.M.; Spencer R.; Avery G.S.; Carbenoxolone: A review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease. Drugs 1976,11(4),245-307","journal-title":"Drugs"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jep.2003.09.044","volume":"90","author":"Suvitayavat W.","year":"2004","unstructured":"Suvitayavat W.; Sumrongkit C.; Thirawarapan S.S.; Bunyapraphatsara N.; Effects of Aloe preparation on the histamine-induced gastric secretion in rats. J Ethnopharmacol 2004,90(2-3),239-247","journal-title":"J Ethnopharmacol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"42","DOI":"10.21477\/ijapsr.v1i1.10174","volume":"1","author":"Reddy V.T.","year":"2016","unstructured":"Reddy V.T.; Kumar S.H.; Bakshi V.; Antiulcer Effect of Formulation of Aloe Vera","journal-title":"Int J App Pharm Sci Res"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"104-119","DOI":"10.1016\/j.fct.2017.07.023","volume":"108","author":"Harsha C.","year":"2017","unstructured":"Harsha C.; Banik K.; Bordoloi D.; Kunnumakkara A.B.; Antiulcer\nproperties of fruits and vegetables: A mechanism based perspective. Food Chem Toxicol 2017,108(Pt A),104-119","journal-title":"Food Chem Toxicol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bj.2018.01.001","volume":"41","author":"Bagheri S.M.","year":"2018","unstructured":"Bagheri S.M.; Zare-Mohazabieh F.; Momeni-Asl H.; Yadegari M.; Mirjalili A.; Anvari M.; Antiulcer and hepatoprotective effects of aqueous extract of Plantago ovata seed on indomethacin-ulcerated rats. Biomed J 2018,41(1),41-45","journal-title":"Biomed J"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jep.2016.07.011","volume":"192","author":"da Silva Junior","year":"2016","unstructured":"da Silva Junior; Balogun S.O.; de Oliveira R.G.; Damazo A.S.; Martins D.T.O.; Piper umbellatum L.: A medicinal plant with gastric-ulcer protective and ulcer healing effects in experimental rodent models. J Ethnopharmacol 2016,192,123-131","journal-title":"J Ethnopharmacol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/etm.2016.3293","volume":"12","author":"Khoder G.","year":"2016","unstructured":"Khoder G.; Al-Menhali A.A.; Al-Yassir F.; Karam S.M.; Potential role of probiotics in the management of gastric ulcer. Exp Ther Med 2016,12(1),3-17","journal-title":"Exp Ther Med"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.3748\/wjg.v21.i14.4345","volume":"21","author":"Zhang M.M.","year":"2015","unstructured":"Zhang M.M.; Qian W.; Qin Y.Y.; He J.; Zhou Y.H.; Probiotics in Helicobacter pylori eradication therapy: A systematic review and meta-analysis. World J Gastroenterol 2015,21(14),4345-4357","journal-title":"World J Gastroenterol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.clinre.2017.04.004","volume":"41","author":"Wang F.","year":"2017","unstructured":"Wang F.; Feng J.; Chen P.; Liu X.; Ma M.; Zhou R.; Chang Y.; Liu J.; Li J.; Zhao Q.; Probiotics in Helicobacter pylori eradication therapy: Systematic review and network meta-analysis. Clin Res Hepatol Gastroenterol 2017,41(4),466-475","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/bjs.1800570414","volume":"57","author":"Johnston D.","year":"1970","unstructured":"Johnston D.; Wilkinson A.R.; Highly selective vagotomy without a drainage procedure in the treatment of duodenal ulcer. Br J Surg 1970,57(4),289-296","journal-title":"Br J Surg"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0168-3659(99)00204-7","volume":"63","author":"Singh B.N.","year":"2000","unstructured":"Singh B.N.; Kim K.H.; Floating drug delivery systems: An approach to oral controlled drug delivery via gastric retention. J Control Release 2000,63(3),235-259","journal-title":"J Control Release"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2005.10.031","volume":"111","author":"Bardonnet P.L.","year":"2006","unstructured":"Bardonnet P.L.; Faivre V.; Pugh W.J.; Piffaretti J.C.; Falson F.; Gastroretentive dosage forms: Overview and special case of Helicobacter pylori. J Control Release 2006,111(1-2),1-18","journal-title":"J Control Release"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ejps.2019.01.025","volume":"132","author":"Raza A.","year":"2019","unstructured":"Raza A.; Shen N.; Li J.; Chen Y.; Wang J-Y.; Formulation of zein based compression coated floating tablets for enhanced gastric retention and tunable drug release. Eur J Pharm Sci 2019,132,163-173","journal-title":"Eur J Pharm Sci"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.fjps.2017.12.002","volume":"4","author":"Patel A.U.","year":"2018","unstructured":"Patel A.U.; Caudhari D.V.; Shah P.J.; Shah S.A.; Hot melt granulation method for the preparation of floating matrix tablets of Tolperison Hydrochloride. Future J Pharm Sci 2018,4,139-149","journal-title":"Future J Pharm Sci"},{"key":"ref=40","first-page":"1361","volume":"5","author":"Chowdary K.P.R.","year":"2014","unstructured":"Chowdary K.P.R.; Chaitanya C.H.K.L.; Recent research on floating drug delivery systems-a review. J Glob Trends Pharm Sci 2014,5,1361-1373","journal-title":"J Glob Trends Pharm Sci"},{"key":"ref=41","first-page":"1","volume":"3","author":"Kaur B.","year":"2013","unstructured":"Kaur B.; Sharma, S.; Sharma, G.; Saini, R.; Singh, S.; Nagpal, M.; Jain, U.K.; Sharma, M. A Review of Floating Drug Delivery System. Asian J Biomed Pharm Sci 2013,3,1-6","journal-title":"Asian J Biomed Pharm Sci"},{"key":"ref=42","first-page":"46","volume":"21","author":"Devtalu S.V.","year":"2013","unstructured":"Devtalu S.V.; Patil A.E.; Bari M.M.; Barhate S.D.; A review on novel approach-bi-layer tablet technology. Int J Pharm Sci Rev Res 2013,21,46-52","journal-title":"Int J Pharm Sci Rev Res"},{"key":"ref=43","first-page":"2534","volume":"2","author":"Deshpande R.D.","year":"2011","unstructured":"Deshpande R.D.; Gowda D.V.; Mahammed N.; Deepak N.; Bi-layer tablets-an emerging trend: A review. Int J Pharm Sci Res 2011,2,2534-2544","journal-title":"Int J Pharm Sci Res"},{"key":"ref=44","first-page":"102","volume":"4","author":"Pujara N.D.","year":"2012","unstructured":"Pujara N.D.; Gokani R.K.; Paun J.S.; Bilayer tablet-an emerging trend. Int J Phar Res Dev 2012,4,102-111","journal-title":"Int J Phar Res Dev"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"10, 06(H), 33255-\n33267","DOI":"10.24327\/IJRSR","author":"Das S.R.","unstructured":"Das S.R.; Panigrahi B.B.; Pani M.K.; A review: On bilayer floating\ntablet as multifunctional approach of gastroretentive drug delivery\nsystem. Int J Recent Scientific Res ,10, 06(H), 33255-\n33267","journal-title":"Int J Recent Scientific Res"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.ijpharm.2013.12.028","volume":"461","author":"Abebe A.","year":"2014","unstructured":"Abebe A.; Akseli I.; Sprockel O.; Kottala N.; Cuiti\u00f1o A.M.; Review of bilayer tablet technology. Int J Pharm 2014,461(1-2),549-558","journal-title":"Int J Pharm"},{"key":"ref=47","first-page":"31","volume":"1","author":"Lende L.K.","year":"2013","unstructured":"Lende L.K.; Banerjee S.K.; Gadhave M.V.; Review on: Bilayer floating tablet. Asian J Pharm Res Dev 2013,1,31-39","journal-title":"Asian J Pharm Res Dev"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jconrel.2013.02.028","volume":"168","author":"Prajapati V.D.","year":"2013","unstructured":"Prajapati V.D.; Jani G.K.; Khutliwala T.A.; Zala B.S.; Raft forming system-an upcoming approach of gastroretentive drug delivery system. J Control Release 2013,168(2),151-165","journal-title":"J Control Release"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"E372","DOI":"10.1208\/pt060347","volume":"6","author":"Arora S.","year":"2005","unstructured":"Arora S.; Ali J.; Ahuja A.; Khar R.K.; Baboota S.; Floating drug delivery systems: A review. AAPS PharmSciTech 2005,6(3),E372-E390","journal-title":"AAPS PharmSciTech"},{"key":"ref=50","first-page":"11","volume":"1","author":"Singh A.K.","year":"2012","unstructured":"Singh A.K.; Dubey V.; Arora V.; Role of natural polymers used in floating drug delivery system. J Pharm Sci Inno 2012,1,11-15","journal-title":"J Pharm Sci Inno"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.ijbiomac.2017.07.087","volume":"105","author":"Muxika A.","year":"2017","unstructured":"Muxika A.; Etxabide A.; Uranga J.; Guerrero P.; de la Caba K.; Chitosan as a bioactive polymer: Processing, properties and applications. Int J Biol Macromol 2017,105(Pt 2),1358-1368","journal-title":"Int J Biol Macromol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.3109\/03639045.2014.917657","volume":"40","author":"Jain D.","year":"2014","unstructured":"Jain D.; Bar-Shalom D.; Alginate drug delivery systems: Application in context of pharmaceutical and biomedical research. Drug Dev Ind Pharm 2014,40(12),1576-1584","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"2018 18;23(4).\npii: E942","DOI":"10.3390\/molecules23040942","author":"Lara-Espinoza C.","unstructured":"Lara-Espinoza C.; Carvajal-Mill\u00e1n E.; Balandr\u00e1n-Quintana R.; L\u00f3pez-Franco Y.; Rasc\u00f3n-Chu A.; Pectin and Pectin-Based Composite\nMaterials: Beyond Food Texture. Molecules. ,2018 18;23(4).\npii: E942"},{"key":"ref=54","first-page":"1144","volume":"3","author":"Swapna B.D.","year":"2014","unstructured":"Swapna B.D.; Abhinay D.; Formulation and evaluation of bilayer tablets of salbutamol sulphate and cetirizine for the treatment of asthma. World J Pharm Pharm Sci 2014,3,1144-1157","journal-title":"World J Pharm Pharm Sci"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"56","DOI":"10.21276\/bpr.2016.6.2.4","volume":"6","author":"Chaurasia V.","year":"2016","unstructured":"Chaurasia V.; Kumar V.; Jain D.; Sumatriptan succinate loaded microspheres containing compressed core tablets for effective treatment of migraine. Bull Pharm Res 2016,6,56-67","journal-title":"Bull Pharm Res"},{"key":"ref=56","first-page":"88","volume":"3","author":"Logidhasan L.","year":"2013","unstructured":"Logidhasan L.; Suresh S.; Mathivanan M.; Formulation and in vitro evaluation of bilayer floating tablets of Aceclofenac and Ranitidine HCl. Int Res J Pharm App Sci 2013,3,88-94","journal-title":"Int Res J Pharm App Sci"},{"key":"ref=57","first-page":"1411","volume":"5","author":"Pethkar S.V.","year":"2016","unstructured":"Pethkar S.V.; Suggala V.; Gholap S.; Review on: Bilayer floating tablet. World J Pharm Pharm Sci 2016,5,1411-1423","journal-title":"World J Pharm Pharm Sci"}],"container-title":["Current Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/175863","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T11:02:54Z","timestamp":1579690974000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/175863\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,27]]},"references-count":57,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,12,27]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567201816666191018163519","relation":{},"ISSN":["1567-2018"],"issn-type":[{"value":"1567-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12,27]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-01-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}